Pava Partners advised DOT GmbH (“DOT”) on the acquisition of all shares in Aristotech Industries GmbH (“Aristotech”).

Aristotech operates one of the last independent forges for orthopedic implants in the European medical technology industry in Luckenwalde near Berlin.

By integrating Aristotech, DOT, one of the world’s leading providers of medical coating technologies for orthopedic implants, will position itself as a one-stop-shop contract manufacturer for implant manufacturers (orthopedic OEMs) in the future.

“Pava Partners supported us in every phase of this process with the utmost professionalism and excellent know-how. The Pava team’s in-depth knowledge of the entire international MedTech industry is particularly noteworthy, regardless of whether it concerns products, manufacturing processes, customers or competitors. We would like to thank the entire team for this excellent cooperation,” says Christian Körtge, Managing Director of DOT.